spacer
home > ebr > summer 2002 > the pivotal role of it systems in drug delivery and innovation
PUBLICATIONS
European Biopharmaceutical Review

The Pivotal Role of IT Systems in Drug Delivery and Innovation

Almost every article about the fate of modern drug discovery or information technology in the life science sector begins by describing the challenges resulting from the enormous data deluge. This article is no exception. The human and mouse genomes have been drafted, the rat genome is awaiting its completion in 2003, high throughput technologies in genomics, screening and chemistry have been established, creating massive amounts of data. There are estimates that even the terabyte scale is already off by an order of magnitude, so when people start talking about petabytes of data, science needs to make sense of it.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Jцrg Sprengel, Executive Project Director i-biology® at LION bioscience AG

Dr Jцrg Sprengel has been with LION bioscience AG since April 2000 and is now Executive Project Director i-biology®. Previously, he spent five years in Belgium at Janssen Research Foundation (JRF), a Johnson & Johnson Company.
In 1997, Jцrg was Head of the Bioinformatic Group at JRF and was honoured for his contribution to the pharmaceutical industry with the Johnson & Johnson Innovation Award. After studying molecular biology, physics and plant physiology, he received a PhD for his work on the genome analysis of human adenovirus type 12 from the University of Cologne.

spacer
Dr Jцrg Sprengel
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers

Igb Tamper Evident Folding Box

IGB

The easiest, safest and less expensive solution in compliance with what requires Dir. 62/2011/EU, FDA and TGA.
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement